[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_2307 

# __Amplification of flawed data through meta-analyses__

## Category to which it belongs

* [Limited and fragmented data availability and interoperability hinder analysis, decision-making, and trust in the reliability of information.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_124.md)

## Closest similar item

* [Amplification of flawed trial data in meta-analyses](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_618.md)
* [Inconsistent use of research evidence](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1350.md)
* [Circulation of misinformation](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2792.md)
* [Inaccurate or sensationalized information](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2757.md)
* [Risk of misdiagnosis or false results](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_839.md)
* [Inaccurate results or bias](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2995.md)
* [Loss of validity](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1375.md)
* [Incomplete or inaccurate data](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3000.md)
* [Lack of credibility as a source of evidence](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_400.md)
* [Inaccurate data](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3130.md)

## Description of the risk

Flawed or fraudulent data can be amplified through meta-analyses, leading to the endorsement of ineffective treatments.

## Is the risk affecting GBN scales

* [No](https://github.com/mm80843/T3.5/blob/main/docs/RiskGBN/PBN__RiskGBN_0.md)

## Type of the risk

* [Other](https://github.com/mm80843/T3.5/blob/main/docs/RiskHealth/PBN__RiskHealth_2.md)

## Type of impact of the risk (according to ISO37100)

* [Innovation, creativity and research](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Purpose_2.md)

## Type of purpose of the risk (according to ISO37100)

* [Attractiveness](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Impact_9.md)

## Mitigations of this risk

* [Meta-analyses should carefully evaluate the quality and reliability of included studies and exclude studies with flawed or fraudulent data.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3031.md)

## Name of the risk

Ineffective treatments may be widely adopted, causing harm to patients and wasting resources.

## Stakeholders who can mitigate this risk

* [Researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)
* [Clinicians](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_274.md)

## Articles mentionning the risk

* [Rise of the preprint: how rapid data sharing during COVID-19 has changed science forever](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_173.md)

## People affected by this risk

* [Researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)
* [Clinicians](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_274.md)

## Technologies linked to the risk

* [Improved evaluation and selection criteria for meta-analyses](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1927.md)

## Property: has_RiskType

* [Technological](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_5.md)

